Sevda Jafari

About Sevda Jafari

Sevda Jafari, With an exceptional h-index of 10 and a recent h-index of 10 (since 2020), a distinguished researcher at Tabriz University of Medical Sciences, specializes in the field of pharmaceutical Biotechnology, Recombinant protein, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.

Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways

Annexin A1, Calreticulin and High Mobility Group Box 1 are elevated in Secondary Progressive Multiple Sclerosis: Does Immunogenic Cell Death Occur in Multiple Sclerosis?

The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells

Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation

Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines

Sevda Jafari Information

University

Position

___

Citations(all)

556

Citations(since 2020)

528

Cited By

89

hIndex(all)

10

hIndex(since 2020)

10

i10Index(all)

10

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Sevda Jafari Skills & Research Interests

pharmaceutical Biotechnology

Recombinant protein

cancer

Top articles of Sevda Jafari

Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.

Current Pharmaceutical Biotechnology

2024/3/12

Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways

Heliyon

2024/2/26

Annexin A1, Calreticulin and High Mobility Group Box 1 are elevated in Secondary Progressive Multiple Sclerosis: Does Immunogenic Cell Death Occur in Multiple Sclerosis?

bioRxiv

2024

The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study

Molecular biology reports

2023/11

Sevda Jafari
Sevda Jafari

H-Index: 6

Elham Ahmadian
Elham Ahmadian

H-Index: 25

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

2023/9/13

Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells

Medical Oncology

2023/8/25

Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation

2023/8/10

Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines

Clinical and Translational Oncology

2023/8

Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy

BioImpacts: BI

2023

Silibinin-loaded nanostructured lipid carriers for growth inhibition of cisplatin-resistant ovarian Cancer cells

ASSAY and Drug Development Technologies

2022/12/1

Recent clinical findings on the role of kinase inhibitors in COVID-19 management

2022/10/1

Development of polymeric micelles loaded with STAT3 inhibitory, stattic, for cancer treatment

Medical Journal of Tabriz University of Medical Sciences

2021/9/15

Renoprotective effects of prazosin on ischemia-reperfusion injury in rats

Human & Experimental Toxicology

2021/8

Stearoylcholine and oleoylcholine: Synthesis, physico-chemical characterization, nanoparticle formation, and toxicity studies

Journal of Drug Delivery Science and Technology

2020/10/1

Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer

2020/10

Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin

Journal of Biomaterials Science, Polymer Edition

2020/6/12

Biomedical Applications of TiO2 Nanostructures: Recent Advances

2020/5/14

Evaluation of the effects of Stattic (a STAT3 inhibitor) on improvement of immunogenic chemotherapy in B16 melanoma cells

2020

Sevda Jafari
Sevda Jafari

H-Index: 6

Efficient Process Development for High‐level Production, Purification, Formulation, and Characterization of Recombinant Mecasermin in E. coli

Biotechnology and Applied Biochemistry

2021/8

Poly (ethylene glycol)-poly (ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin

Bioimpacts

2020

See List of Professors in Sevda Jafari University(Tabriz University of Medical Sciences)

Co-Authors

academic-engine